Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen. [electronic resource]
Producer: 20111219Description: 215-21 p. digitalISSN:- 1868-8500
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Estrogen Receptor alpha -- metabolism
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Middle Aged
- Multivariate Analysis
- Phosphorylation
- Receptor, ErbB-2 -- metabolism
- Tamoxifen -- therapeutic use
- Tissue Array Analysis
- Treatment Outcome
- Tyrosine -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.